Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Okklo Life Sciences BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10964
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. Okklo provides technology platform such as Cyclodextrins, OCTOPlex and Therapeutic CDs. The company’s OCTOPlex technology can be used to inactivate a wide range of drugs or harmful biological metabolites that accumulate in certain disease states that need to be detoxified. The company develops sugammadex, the first modified cyclodextrin. Okklo is headquartered in Nijmegen, the Netherlands.

Okklo Life Sciences BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Okklo Life Sciences BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Okklo Life Sciences BV, Medical Devices Deals, 2012 to YTD 2018 9
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 11
Okklo Life Sciences and SolAeroMed Enter into Partnership 12
Okklo Life Sciences Enters Into Research Agreement with BioAxis 13
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 14
Okklo Life Sciences BV – Key Competitors 15
Okklo Life Sciences BV – Key Employees 16
Okklo Life Sciences BV – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Other Significant Developments 18
Jun 07, 2018: Blood test may identify pregnant women at risk of premature birth 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Key Facts 2
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Okklo Life Sciences BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Okklo Life Sciences BV, Deals By Therapy Area, 2012 to YTD 2018 8
Okklo Life Sciences BV, Medical Devices Deals, 2012 to YTD 2018 9
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 11
Okklo Life Sciences and SolAeroMed Enter into Partnership 12
Okklo Life Sciences Enters Into Research Agreement with BioAxis 13
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 14
Okklo Life Sciences BV, Key Competitors 15
Okklo Life Sciences BV, Key Employees 16

List of Figures
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Okklo Life Sciences BV, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MeVis Medical Solutions AG (M3V):医療機器:M&Aディール及び事業提携情報
    Summary MeVis Medical Solutions AG (MMS AG), a subsidiary of Varian Medical Systems, Inc., is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company’s software solu …
  • Concho Resources Inc (CXO):企業の財務・戦略的SWOT分析
    Summary Concho Resources Inc (Concho) is an oil and gas company. It acquires, develops, produces and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in t …
  • Oasis Petroleum Inc (OAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Oasis Petroleum Inc. (Oasis Petroleum) is an independent exploration and production company. It focuses on the acquisition and development of unconventional oil and natural gas resources. The company operates in the Williston Basin in North Dakota and Montana and Permian Basin. The company f …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • Carrizo Oil & Gas, Inc. (CRZO)-石油・ガス分野:企業M&A・提携分析
    Summary Carrizo Oil & Gas, Inc. (Carrizo) is an independent oil and gas company, which carries out exploration, development and production of oil and natural gas from several resources plays. It has presence in the Marcellus Shale in Pennsylvania, the Eagle Ford Shale in South Texas, the Niobrara Fo …
  • ABB Ltd (ABBN):企業の財務・戦略的SWOT分析
    ABB Ltd (ABBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Foamix Pharmaceuticals Ltd (FOMX):企業の財務・戦略的SWOT分析
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • NewYork-Presbyterian Hospital:企業の戦略的SWOT分析
    NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sime Darby Berhad:企業の戦略・SWOT・財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tenet Healthcare Corp (THC)-製薬・医療分野:企業M&A・提携分析
    Summary Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, wi …
  • Kuwait Investment Authority:電力:M&Aディール及び事業提携情報
    Summary The Kuwait Investment Authority (KIA) is an asset management company. It offers fund management and investment management services. The company is responsible for the management and administration of the General Reserve Fund (GRF), apart from the assets of the Future Generations Fund (FGF). …
  • Pt Bumi Resources Tbk
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Navios Maritime Acquisition Corp:企業のM&A・事業提携・投資動向
    Navios Maritime Acquisition Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Acquisition Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Guangdong Biolight Meditech Co Ltd (300246):医療機器:M&Aディール及び事業提携情報
    Summary Guangdong Biolight Meditech Co Ltd (Biolight) is a medical device company. The company operates in the business of research, development, production and sale of medical treatment monitors, medical consumables and healthcare solutions. It offers patient monitors, hemodialysis products and hom …
  • Shine Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shine Medical Technologies Inc (Shine Medical) is a manufacturer and supplier of medical tracers and cancer treatment elements. The company’s products include molybdenum-99 is the parent isotope of technetium 99m for diagnosing and staging multitude of diseases, including cancer and heart di …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • Amdocs Limited:企業の戦略・SWOT・財務情報
    Amdocs Limited - Strategy, SWOT and Corporate Finance Report Summary Amdocs Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tourmaline Oil Corp.:企業のM&A・事業提携・投資動向
    Tourmaline Oil Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tourmaline Oil Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆